{
  "version": "1.0",
  "type": "link",
  "title": "Pharma Pharmacovigilance, Medical Affairs & Regulatory Submission Lines (Finland) — COO Agent Operations | ANDYGROVE.SYSTEMS",
  "author_name": "ANDYGROVE.SYSTEMS Continuing Professional Development & Operations Research Collective",
  "author_url": "https://andygrove.systems/education",
  "provider_name": "ANDYGROVE.SYSTEMS — High Output Operations & Fresh Preprints Upskilling Hub",
  "provider_url": "https://andygrove.systems",
  "cache_age": 86400,
  "thumbnail_url": "https://andygrove.systems/og-card.png",
  "thumbnail_width": 1200,
  "thumbnail_height": 630,
  "url": "https://andygrove.systems/finland/coo-pharma-pharmacovigilance-regulatory",
  "description": "Pharma Pharmacovigilance, Medical Affairs & Regulatory Submission Lines in Finland (GxP / 21 CFR Part 11 / 7- & 15-Day ICSR Adverse Event Reporting). Governing COO law: 100% L1 Medical Reviewer Gate on Serious ICSRs + Halfin–Whitt Surge Pods. Request a scoped 1-Page Agent Line Audit or engage $20–45/hr IE/OR pods (Aalto University (Dept. of Industrial Engineering and Management & Systems Analysis Laboratory), Tampere University, LUT University, University of Oulu). | Fresh Preprints: https://andygrove.systems/preprints | 42-Hr CPD Hub: https://andygrove.systems/education (Independent; not affiliated with Intel Corporation or the Grove family)"
}